Scarica l'app Stockscreener
3.64
0.85%
-0.0313
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMRA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.6713
Aprire:
$3.65
Volume 24 ore:
15,662
Relative Volume:
0.27
Capitalizzazione di mercato:
$9.28M
Reddito:
$5.51M
Utile/perdita netta:
$-6.16M
Rapporto P/E:
-9.8378
EPS:
-0.37
Flusso di cassa netto:
$-5.03M
1 W Prestazione:
+1.68%
1M Prestazione:
+8.31%
6M Prestazione:
+30.34%
1 anno Prestazione:
-25.04%
Intervallo 1D:
$3.5101
$3.70
Intervallo di 1 settimana:
$3.4011
$3.74
Portata 52W:
$1.932
$10.16
Biomerica Inc Stock (BMRA) Company Profile
Nome
Biomerica Inc
Settore
Industria
Telefono
(949) 379-2875
Indirizzo
17571 VON KARMAN AVENUE, IRVINE, CA
Confronta BMRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
3.64 | 9.11M | 5.51M | -6.16M | -5.03M | -0.37 |
|
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-11-10 | Iniziato | Colliers Securities | Buy |
| 2018-01-04 | Iniziato | B. Riley FBR, Inc. | Buy |
Biomerica Inc Borsa (BMRA) Ultime notizie
Biomerica, Inc. and CLIA Laboratory Partner Filed for inFoods IBS Test - marketscreener.com
Biomerica submits application for PLA code for inFoods IBS diagnostic test - TipRanks
Biomerica (BMRA) Seeks New CPT Code for IBS Diagnostic Test | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS TestA Key Step Toward Reimbursement - The Manila Times
PLA Code Application Filed for inFoods IBS Test -- A Key Step Toward Reimbursement | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement - Stock Titan
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed - MSN
Biomerica (NASDAQ:BMRA) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell? - American Banking and Market News
Biomerica announces Fortel Ulcer Test approved for sale by UAE Ministry - TipRanks
Biomerica (BMRA) Gains UAE Approval for Fortel Ulcer Test | BMRA Stock News - GuruFocus
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection - The Manila Times
United Arab Emirates Ministry of Health and Prevention Approves - GuruFocus
BMRA Stock Might Surge: Biomerica’s New Ulcer Test Now Available Across the UAE - Own Snap
United Arab Emirates Ministry Of Health And Prevention Approves Biomerica'S Fortel® Ulcer Test For Detection Of H. Pylori Infection - marketscreener.com
Biomerica Secures Major UAE Approval for Rapid H. Pylori Test as Middle East Expansion Accelerates - Stock Titan
BMRA stock touches 52-week high of $3.84 amid market fluctuations - Investing.com
Financial Health Report: Biomerica Inc (BMRA)’s Ratios Tell a Tale - DWinneX
BMRA stock touches 52-week high of $3.84 amid market fluctuations By Investing.com - Investing.com South Africa
Biomerica’s kidney disease test gains approval for sale in UAE - Yahoo Finance
Biomerica stock plummets on 1-for-8 reverse stock split - MSN
Biomerica’s kidney disease test approved for UAE market By Investing.com - Investing.com Canada
Walmart to Expand Sales of BiomericaÆS Aware Breast Self Exam; Product Will Now Be Available in over 2400 Walmart Stores - marketscreener.com
Biomerica (BMRA) Gains UAE Approval for Fortel Kidney Disease Te - GuruFocus
BiomericaFortel Kidney Disease Test Approved For Sale In UAE - marketscreener.com
Biomerica’s kidney disease test approved for UAE market - Investing.com Australia
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - The Manila Times
Revolutionary 10-Minute Test Could Help Detect Hidden Kidney Disease in 80% of At-Risk Patients - Stock Titan
Biomerica Stock Set to Reverse Split on Monday, April 21st (NASDAQ:BMRA) - Defense World
Biomerica announces reverse stock split - Medical Buyer
Biomerica announces reverse stock split to meet Nasdaq requirements - Investing.com Australia
Biomerica announces reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Canada
Crude Oil Moves Higher; Travelers Earnings Beat Estimates - Benzinga
Biomerica Announced 1-for-8 Reverse Stock Split - Nasdaq
Biomerica Plans Reverse Stock Split to Regain Nasdaq Listing Compliance - marketscreener.com
Biomerica Announces 1-for-8 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings - Benzinga
Biomerica (BMRA) Announces 1-for-8 Reverse Stock Split Effective April 2025 | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split Effective April 21 - TipRanks
Biomerica, Inc. Announces 1-for-8 Reverse Stock Split Effective April 21, 2025 - Nasdaq
Biomerica's Strategic 1:8 Reverse Split Aims to Secure Nasdaq Future - Stock Titan
3 High-Value Companies With Triple-Digit Upside Potential - The Globe and Mail
Biomerica Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
Biomerica Reports Third Quarter Fiscal 2025 Financial Results | - GuruFocus
Biomerica (BMRA) Reports Q3 Revenue Increase and Lower Expenses - GuruFocus
Wheat Losses Continuing on Tuesday Morning - The Globe and Mail
Biomerica Turns Corner: 10% Growth, Cost Cuts, and Major Regulatory Wins Boost Q3 Results - Stock Titan
BIOMERICA INC SEC 10-Q Report - TradingView
La Mancha Investment buying more Belo Sun Mining (BSX) - The Globe and Mail
Biomerica Inc Azioni (BMRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.85%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):